Oral CCR5 inhibitors: will they make it through? - Wikidata - wikimedia - TriplyDB

Oral CCR5 inhibitors: will they make it through?

Oral CCR5 inhibitors: will they make it through?

http://www.wikidata.org/entity/Q36458354

about

Access denied? The status of co-receptor inhibition to counter HIV entry Characterization of HIV-1 entry inhibitors with broad activity against R5 and X4 viral strains.

P2860

Q28300187-92C1A4DE-F956-46DD-81EE-0558DFEF710D Q35441620-E4D89DCB-B124-4CA4-9222-BEF10A288F22

P2860

Oral CCR5 inhibitors: will they make it through?

http://www.wikidata.org/entity/Q36458354

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh

2006年學術文章

@zh-hant

name

Oral CCR5 inhibitors: will they make it through?

@ast

Oral CCR5 inhibitors: will they make it through?

@en

type

label

Oral CCR5 inhibitors: will they make it through?

@ast

Oral CCR5 inhibitors: will they make it through?

@en

prefLabel

Oral CCR5 inhibitors: will they make it through?

@ast

Oral CCR5 inhibitors: will they make it through?

@en

P1433

Q36458354-4272346F-29F2-49C0-8A9C-69D37C20C25D

P1476

Q36458354-CCF366B3-428C-4905-8BEB-4FD8E286ECB4

P2860

Q36458354-02B3B756-E1A9-4876-8B88-DAD9F0A07CBB

Q36458354-054FC22E-006D-419D-80B7-635A80BB5B28

Q36458354-07050766-33BE-489A-915E-77CEE3EE5FEB

Q36458354-083E82A8-D431-4E5C-BD97-5C7C39D04C19

Q36458354-08768957-60C0-45C9-8BB3-C069603BAB86

Q36458354-0A6464C4-C642-4290-981A-074315C5C834

Q36458354-0BCE55C4-8C02-45C0-966A-3E56AF257B31

Q36458354-12F1166A-D18D-4D82-B732-6146749E7341

Q36458354-14B9D279-1115-4465-9194-A558BE17307F

Q36458354-1A0E01DF-7A4B-46BE-9BFF-684D913D810A

P304

Q36458354-3271B7E8-29B6-4D88-8DF1-D44FFB5854CE

P31

Q36458354-A8A1D92C-0A47-4C8D-88EB-54549DC5499A

Q36458354-b4032cd1-1049-41e8-b035-94a05babb28c

P356

Q36458354-E4496980-889E-4C70-927D-C251CC586AB5

P407

Q36458354-7FB2A3A1-9408-46B9-8666-0D1E4EC1E7BA

P433

Q36458354-D7EDF381-2111-4ED2-8809-0618D3DA8759

P478

Q36458354-1C5C3F21-F1BF-43A8-A722-2F5CD6473F15

P50

Q36458354-0FDEA925-CBB3-4EA4-A68C-7F4726249C01

Q36458354-9E8A7DDF-7543-4A0F-B70C-5ED67B3EF481

Q36458354-A1045408-835D-4494-AE3F-2A66F1E06AA4

Q36458354-B8DA069A-51E9-4D5D-8874-69C494D2762A

Q36458354-B973EFC1-6AB5-4470-9C04-FC82D1D2C921

P577

Q36458354-7D85D5FD-F525-4711-B425-B07E2F93F527

P698

Q36458354-0C8AFFE5-8CBF-4CB0-A477-67E2E88A02B1

P356

13543784.15.5.451

P1433

Expert Opinion on Investigational Drugs

P1476

Oral CCR5 inhibitors: will they make it through?

@en

P2860

Assessing chemokine co-receptor usage in HIV

Discovery and characterization of vicriviroc (SCH 417690), a CCR5 antagonist with potent activity against human immunodeficiency virus type 1

Spirodiketopiperazine-based CCR5 inhibitor which preserves CC-chemokine/CCR5 interactions and exerts potent activity against R5 human immunodeficiency virus type 1 in vitro

HIV and the chemokine system: 10 years later.

HIV coreceptors: role of structure, posttranslational modifications, and internalization in viral-cell fusion and as targets for entry inhibitors

Piperazine-based CCR5 antagonists as HIV-1 inhibitors. IV. Discovery of 1-[(4,6-dimethyl-5-pyrimidinyl)carbonyl]- 4-[4-[2-methoxy-1(R)-4-(trifluoromethyl)phenyl]ethyl-3(S)-methyl-1-piperazinyl]- 4-methylpiperidine (Sch-417690/Sch-D), a potent, highl

Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells

Human immunodeficiency virus (HIV) entry inhibitors (CCR5 specific blockers) in development: are they the next novel therapies?

HIV-1 escape from a small molecule, CCR5-specific entry inhibitor does not involve CXCR4 use

SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivo

P304

451-464

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543784.15.5.451

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

Giuseppe Tambussi

Priscilla Biswas

Adriano Lazzarin

Gabriella Scarlatti

P577

2006-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16634684

http://www.w3.org/2001/XMLSchema#string